BioPharm Insight, the premier source for exclusive breaking news and forward-looking analysis about drug development and forecasting data, today released its 2014 third quarter report on CRO activity, revealing that although the volume of clinical trials increased over the same quarter in 2013, the number of trials conducted in North America going from 48 percent to just 43 percent of the total year to year. The quarterly report also reveals key CRO opportunities, financing and likely IPOs that are imminent within pharmaceutical and biotech sectors.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
